These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7452450)

  • 21. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
    Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
    Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enterohepatic circulation in rat and dog of 14C-0-[3-(4-less than 2-methoxyphenyl greater than-1-piperazinyl)-2-hydroxypropyl]-3-methoxy-benzaldoxim dihydrochloride and it's demethylated metabolite.
    Paul H; Illing A; House ES
    Eur J Drug Metab Pharmacokinet; 1981; 6(4):303-12. PubMed ID: 7333331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disposition of 4,5-diphenyl-2-oxazolepropionic acid (oxaprozin) in beagle dogs and rhesus monkeys.
    Janssen FW; Kirkman SK; Knowles JA; Ruelius HW
    Drug Metab Dispos; 1978; 6(4):465-75. PubMed ID: 28928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans.
    Weinz C; Schwarz T; Kubitza D; Mueck W; Lang D
    Drug Metab Dispos; 2009 May; 37(5):1056-64. PubMed ID: 19196845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Excretion and metabolism of lorcainide in rats, dogs and man.
    Meuldermans W; Hurkmans R; Swysen E; Hendrickx J; Thijssen J; Lauwers W; Heykants J
    Eur J Drug Metab Pharmacokinet; 1983; 8(4):335-49. PubMed ID: 6673971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Excretion and metabolism of intramuscularly administered [14C]-haloperidol decanoate in rats.
    Matsunaga Y; Nambu K; Oh-e Y; Miyazaki H; Hashimoto M
    Arzneimittelforschung; 1986 Mar; 36(3):453-6. PubMed ID: 3707664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans.
    Denissen JF; Grabowski BA; Johnson MK; Buko AM; Kempf DJ; Thomas SB; Surber BW
    Drug Metab Dispos; 1997 Apr; 25(4):489-501. PubMed ID: 9107549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of the new pyrimidine derivative NS-7, a novel Na+/Ca2+ channel blocker. 1st communication: plasma concentrations and excretions after a single intravenous 14C-NS-7 injection to rats, dogs and monkeys.
    Nonaka K; Tsujioka T; Tougou K; Mukai H
    Arzneimittelforschung; 2003; 53(9):612-20. PubMed ID: 14558434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disposition of sucrose octa-isobutyrate in rats, dogs and monkeys.
    Noker PE; Kalin JR; McCarthy DJ; el Dareer SM; Chappel CI
    Food Chem Toxicol; 1986 Dec; 24(12):1287-93. PubMed ID: 3100405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolism and disposition of a potent and selective JNK inhibitor [14C]tanzisertib following oral administration to rats, dogs and humans.
    Atsriku C; Hoffmann M; Ye Y; Kumar G; Surapaneni S
    Xenobiotica; 2015 May; 45(5):428-41. PubMed ID: 25482583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Species differences in the biotransformation of an alpha 4 beta 2 nicotinic acetylcholine receptor partial agonist: the effects of distinct glucuronide metabolites on overall compound disposition.
    Shaffer CL; Gunduz M; Ryder TF; O'Connell TN
    Drug Metab Dispos; 2010 Feb; 38(2):292-301. PubMed ID: 19910512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolism and disposition of [14C]BMS-690514 after oral administration to rats, rabbits, and dogs.
    Hong H; Su H; Sun H; Allentoff A; Ekhato IV; Chando T; Caceres-Cortes J; Roongta V; Iyer RA; Humphreys WG; Christopher LJ
    Drug Metab Dispos; 2010 Jul; 38(7):1189-201. PubMed ID: 20363952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biliary excretion, metabolism and enterohepatic circulation of buprenorphine.
    Brewster D; Humphrey MJ; McLeavy MA
    Xenobiotica; 1981 Mar; 11(3):189-96. PubMed ID: 7293215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolism of labetalol by animals and man.
    Martin LE; Hopkins R; Bland R
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Excretion and biotransformation of alfentanil and sufentanil in rats and dogs.
    Meuldermans W; Hendrickx J; Lauwers W; Hurkmans R; Swysen E; Thijssen J; Timmerman P; Woestenborghs R; Heykants J
    Drug Metab Dispos; 1987; 15(6):905-13. PubMed ID: 2893720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disposition and metabolism of olanzapine in mice, dogs, and rhesus monkeys.
    Mattiuz E; Franklin R; Gillespie T; Murphy A; Bernstein J; Chiu A; Hotten T; Kassahun K
    Drug Metab Dispos; 1997 May; 25(5):573-83. PubMed ID: 9152596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics, metabolism, and excretion of the glycogen synthase kinase-3 inhibitor LY2090314 in rats, dogs, and humans: a case study in rapid clearance by extensive metabolism with low circulating metabolite exposure.
    Zamek-Gliszczynski MJ; Abraham TL; Alberts JJ; Kulanthaivel P; Jackson KA; Chow KH; McCann DJ; Hu H; Anderson S; Furr NA; Barbuch RJ; Cassidy KC
    Drug Metab Dispos; 2013 Apr; 41(4):714-26. PubMed ID: 23305709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the pharmacokinetics of domperidone in animals and man III. Comparative study on the excretion and metabolism of domperidone in rats, dogs and man.
    Meuldermans W; Hurkmans R; Swysen E; Hendrickx J; Michiels M; Lauwers W; Heykants J
    Eur J Drug Metab Pharmacokinet; 1981; 6(1):49-60. PubMed ID: 6788556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
    Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.